ABSTRACT
Many patients with gout have comorbidities, including hypertension and chronic kidney disease (CKD). The goals when treating gout are no different in these patients, but the choice and dosage of drugs may need to be modified.
Footnotes
↵* Dr. Mandell has disclosed that he has been a consultant for Takeda Pharmaceutical Company and has conducted a clinical trial for Savient Pharmaceuticals.
- Copyright © 2010 The Cleveland Clinic Foundation. All Rights Reserved.
Log in using your username and password
Registration is Now Required for Free Access to CCJM Content
Register once and log in for full access to articles and content. Click “Register” in the upper right corner and follow the simple instructions to create a new account.
If you are using a mobile device, click on the settings icon to access the Register link.
Managing gout: How is it different in patients with chronic kidney disease?
